GlassScriptPhysician profile
Nicholas Salerno
NPI 1083147698
$18,639.84
in general payments reported to CMS, 2019-2025
23 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $142 · 2021: $1,080 · 2022: $1,510 · 2023: $1,429 · 2024: $2,051 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,100 · Food and Beverage: $6,239 · Travel and Lodging: $1,513 · Education: $55.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,100.00 |
| Food and Beverage | $6,239.05 |
| Travel and Lodging | $1,513.44 |
| Education | $55.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $11,107.65 | 2023-2025 | Novosorb Btm |
| Treace Medical Concepts, INC. | $2,070.66 | 2025 | |
| Smith+Nephew, INC. | $878.77 | 2021-2025 | Collagenase Santyl, Regranex, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Stryker Corporation | $673.78 | 2020-2024 | Hoffmann, Variax, Salvation |
| Musculoskeletal Transplant Foundation INC. | $637.35 | 2021 | |
| Integra Lifesciences Corporation | $456.75 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $391.70 | 2022-2025 | Restrata Wound Matrix |
| Organogenesis INC. | $357.82 | 2022-2023 | Puraply |
| Nevro Corp. | $339.34 | 2021-2022 | |
| Mimedx Group, INC. | $249.69 | 2024-2025 | |
| Arteriocyte Medical Systems, INC. | $240.83 | 2023 | Magellan |
| Novastep INC. | $205.64 | 2022 | |
| Orthofix Medical, INC. | $197.25 | 2024 | Physio-Stim |
| Tactile Systems Technology INC | $152.29 | 2021-2025 | Nimbl, Flexitouch Plus |
| Medline Industries LP | $147.41 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cagent Vascular INC | $130.30 | 2023 | Serrantor |
| Grt US Holding, INC. | $125.00 | 2022 | |
| Next Science LLC | $106.74 | 2025 | Xperience, Blastx |
| Kerecis Limited | $47.59 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $47.10 | 2024 | Intellis Adaptivestim |
| Solventum Corporation | $41.33 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Abbvie INC. | $22.09 | 2023 | Dalvance |
| Misonix INC | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Salerno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.